| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 4.11e-07 | 5 | 70 | 3 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.43e-06 | 7 | 70 | 3 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.43e-06 | 7 | 70 | 3 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 4.86e-06 | 10 | 70 | 3 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 4.86e-06 | 10 | 70 | 3 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 4.86e-06 | 10 | 70 | 3 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.15e-05 | 13 | 70 | 3 | GO:0016713 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.02e-05 | 46 | 70 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 7.92e-05 | 24 | 70 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.14e-04 | 27 | 70 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | aromatase activity | 2.49e-04 | 35 | 70 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 3.71e-04 | 40 | 70 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.17e-04 | 188 | 70 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 6.25e-04 | 196 | 70 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 6.77e-04 | 49 | 70 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 7.82e-04 | 12 | 70 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 9.22e-04 | 13 | 70 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | arachidonate binding | 1.24e-03 | 15 | 70 | 2 | GO:0050544 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.39e-03 | 477 | 70 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | icosanoid binding | 1.41e-03 | 16 | 70 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 1.41e-03 | 16 | 70 | 2 | GO:0050543 | |
| GeneOntologyMolecularFunction | transporter activity | SLC6A18 GRAMD1B SLC41A2 ABCC3 SLC4A8 ABCA6 GRAMD1A XKR8 SLC39A14 NDUFA10 SLC14A2 SLC35B1 | 1.62e-03 | 1289 | 70 | 12 | GO:0005215 |
| GeneOntologyMolecularFunction | cholesterol transfer activity | 3.18e-03 | 24 | 70 | 2 | GO:0120020 | |
| GeneOntologyMolecularFunction | sterol transfer activity | 3.45e-03 | 25 | 70 | 2 | GO:0120015 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.73e-03 | 26 | 70 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 4.32e-03 | 28 | 70 | 2 | GO:0036041 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 6.25e-08 | 12 | 71 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 3.80e-07 | 18 | 71 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 7.76e-07 | 6 | 71 | 3 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 1.35e-06 | 7 | 71 | 3 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 2.16e-06 | 8 | 71 | 3 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 6.32e-06 | 11 | 71 | 3 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 8.41e-06 | 12 | 71 | 3 | GO:0042758 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 3.50e-05 | 3 | 71 | 2 | GO:0042361 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 4.51e-05 | 377 | 71 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 4.59e-05 | 378 | 71 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 4.68e-05 | 379 | 71 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 5.74e-05 | 22 | 71 | 3 | GO:1901569 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 6.87e-05 | 124 | 71 | 5 | GO:0001676 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 6.98e-05 | 4 | 71 | 2 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 6.98e-05 | 4 | 71 | 2 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 6.98e-05 | 4 | 71 | 2 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 6.98e-05 | 4 | 71 | 2 | GO:0042377 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 8.89e-05 | 68 | 71 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 1.74e-04 | 6 | 71 | 2 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 1.74e-04 | 6 | 71 | 2 | GO:0062232 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 3.79e-04 | 41 | 71 | 3 | GO:0006691 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 3.91e-04 | 180 | 71 | 5 | GO:0120254 | |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 6.30e-04 | 11 | 71 | 2 | GO:0042373 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 6.90e-04 | 116 | 71 | 4 | GO:0009062 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 7.54e-04 | 12 | 71 | 2 | GO:0042363 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 7.41e-07 | 21 | 72 | 4 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 7.78e-07 | 6 | 72 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.17e-06 | 8 | 72 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.17e-06 | 8 | 72 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.17e-06 | 8 | 72 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | basement membrane | 6.38e-05 | 122 | 72 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.46e-04 | 332 | 72 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | collagen trimer | 2.42e-04 | 88 | 72 | 4 | GO:0005581 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-plasma membrane contact site | 8.90e-04 | 13 | 72 | 2 | GO:0140268 | |
| GeneOntologyCellularComponent | apical part of cell | SLC6A18 SLC4A8 CYP4F3 CYP4F12 SLC39A14 NEDD1 SLC14A2 CYP4F11 | 9.60e-04 | 592 | 72 | 8 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | 1.42e-03 | 487 | 72 | 7 | GO:0016324 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.84e-03 | 656 | 72 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.88e-03 | 658 | 72 | 8 | GO:0030312 | |
| HumanPheno | Lenticonus | 9.45e-06 | 10 | 23 | 3 | HP:0001142 | |
| HumanPheno | Glomerular basement membrane lamellation | 5.84e-05 | 3 | 23 | 2 | HP:0030034 | |
| HumanPheno | Abnormality of lens shape | 6.28e-05 | 18 | 23 | 3 | HP:0011526 | |
| HumanPheno | Prolonged bleeding time | 6.34e-05 | 50 | 23 | 4 | HP:0003010 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 3.91e-05 | 44 | 61 | 4 | MP:0011348 | |
| MousePheno | hematuria | 7.29e-05 | 19 | 61 | 3 | MP:0005161 | |
| MousePheno | abnormal lens capsule morphology | 8.55e-05 | 20 | 61 | 3 | MP:0003236 | |
| Domain | C4 | 1.00e-06 | 6 | 70 | 3 | SM00111 | |
| Domain | - | 1.00e-06 | 6 | 70 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.00e-06 | 6 | 70 | 3 | IPR001442 | |
| Domain | C4 | 1.00e-06 | 6 | 70 | 3 | PF01413 | |
| Domain | NC1_IV | 1.00e-06 | 6 | 70 | 3 | PS51403 | |
| Domain | VAST | 4.14e-05 | 3 | 70 | 2 | PS51778 | |
| Domain | DUF4782 | 4.14e-05 | 3 | 70 | 2 | IPR031968 | |
| Domain | DUF4782 | 4.14e-05 | 3 | 70 | 2 | PF16016 | |
| Domain | CTDL_fold | 5.06e-05 | 107 | 70 | 5 | IPR016187 | |
| Domain | Collagen | 2.91e-04 | 85 | 70 | 4 | IPR008160 | |
| Domain | Collagen | 2.91e-04 | 85 | 70 | 4 | PF01391 | |
| Domain | Cyt_P450_E_grp-I | 6.39e-04 | 45 | 70 | 3 | IPR002401 | |
| Domain | Cyt_P450_CS | 1.03e-03 | 53 | 70 | 3 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 1.28e-03 | 57 | 70 | 3 | PS00086 | |
| Domain | - | 1.34e-03 | 58 | 70 | 3 | 1.10.630.10 | |
| Domain | p450 | 1.34e-03 | 58 | 70 | 3 | PF00067 | |
| Domain | Cyt_P450 | 1.48e-03 | 60 | 70 | 3 | IPR001128 | |
| Domain | GRAM | 1.61e-03 | 16 | 70 | 2 | SM00568 | |
| Domain | - | 1.61e-03 | 16 | 70 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.61e-03 | 16 | 70 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 2.04e-03 | 18 | 70 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.04e-03 | 18 | 70 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 2.04e-03 | 18 | 70 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 2.04e-03 | 18 | 70 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.04e-03 | 18 | 70 | 2 | PS00916 | |
| Domain | GRAM | 3.05e-03 | 22 | 70 | 2 | PF02893 | |
| Domain | GRAM | 3.05e-03 | 22 | 70 | 2 | IPR004182 | |
| Domain | HormR | 3.93e-03 | 25 | 70 | 2 | SM00008 | |
| Domain | HRM | 4.91e-03 | 28 | 70 | 2 | PF02793 | |
| Domain | GPCR_2_secretin-like_CS | 7.19e-03 | 34 | 70 | 2 | IPR017983 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.95e-07 | 15 | 56 | 4 | M27161 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.03e-06 | 20 | 56 | 4 | MM15061 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.87e-06 | 23 | 56 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.87e-06 | 23 | 56 | 4 | MM1427 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.50e-06 | 59 | 56 | 5 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.14e-06 | 61 | 56 | 5 | M27103 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.67e-06 | 30 | 56 | 4 | M27216 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 6.13e-06 | 66 | 56 | 5 | M18 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 6.99e-06 | 10 | 56 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 6.99e-06 | 10 | 56 | 3 | MM1560 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.39e-06 | 32 | 56 | 4 | MM14924 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 9.58e-06 | 11 | 56 | 3 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.27e-05 | 12 | 56 | 3 | MM1526 | |
| Pathway | REACTOME_EICOSANOIDS | 1.27e-05 | 12 | 56 | 3 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 1.27e-05 | 12 | 56 | 3 | MM14845 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.49e-05 | 38 | 56 | 4 | MM14969 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.65e-05 | 13 | 56 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.65e-05 | 13 | 56 | 3 | M12950 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.03e-05 | 41 | 56 | 4 | MM15538 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.10e-05 | 14 | 56 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.10e-05 | 14 | 56 | 3 | M6487 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 2.10e-05 | 14 | 56 | 3 | MM15842 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.23e-05 | 42 | 56 | 4 | M7169 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.61e-05 | 15 | 56 | 3 | M27126 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.61e-05 | 15 | 56 | 3 | MM14922 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.69e-05 | 44 | 56 | 4 | M27812 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.80e-05 | 90 | 56 | 5 | M631 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 3.22e-05 | 46 | 56 | 4 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.49e-05 | 50 | 56 | 4 | MM14796 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 4.64e-05 | 18 | 56 | 3 | M27164 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 4.64e-05 | 18 | 56 | 3 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 4.64e-05 | 18 | 56 | 3 | MM14841 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 4.64e-05 | 18 | 56 | 3 | MM14882 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.66e-05 | 53 | 56 | 4 | MM14566 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 6.45e-05 | 20 | 56 | 3 | M15394 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.54e-05 | 57 | 56 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 8.08e-05 | 58 | 56 | 4 | M2049 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.85e-05 | 61 | 56 | 4 | MM14637 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.12e-04 | 63 | 56 | 4 | M11187 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.19e-04 | 64 | 56 | 4 | M26953 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.28e-04 | 25 | 56 | 3 | MM14858 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.42e-04 | 67 | 56 | 4 | M26999 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.09e-04 | 74 | 56 | 4 | M160 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.29e-04 | 140 | 56 | 5 | M587 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.32e-04 | 76 | 56 | 4 | MM15072 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.32e-04 | 76 | 56 | 4 | MM14867 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.32e-04 | 76 | 56 | 4 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.32e-04 | 76 | 56 | 4 | MM14573 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 2.98e-04 | 33 | 56 | 3 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 2.98e-04 | 33 | 56 | 3 | MM15963 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.40e-04 | 84 | 56 | 4 | M27334 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.40e-04 | 84 | 56 | 4 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.56e-04 | 85 | 56 | 4 | M16441 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.66e-04 | 96 | 56 | 4 | M39834 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 6.55e-04 | 43 | 56 | 3 | M53 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 8.33e-04 | 11 | 56 | 2 | MM14863 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 9.97e-04 | 12 | 56 | 2 | M27128 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.08e-03 | 114 | 56 | 4 | MM14571 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.82e-03 | 61 | 56 | 3 | MM14861 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.90e-03 | 62 | 56 | 3 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.08e-03 | 64 | 56 | 3 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.28e-03 | 66 | 56 | 3 | MM14839 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.49e-03 | 238 | 56 | 5 | MM15076 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 2.81e-03 | 20 | 56 | 2 | MM15077 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.03e-03 | 249 | 56 | 5 | M5988 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.10e-03 | 21 | 56 | 2 | M27137 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 3.47e-03 | 157 | 56 | 4 | M4904 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 3.57e-03 | 502 | 56 | 7 | MM14537 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 3.80e-03 | 161 | 56 | 4 | M39770 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 4.04e-03 | 24 | 56 | 2 | MM15992 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 4.04e-03 | 24 | 56 | 2 | M39643 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 4.04e-03 | 24 | 56 | 2 | M18795 | |
| Pubmed | 8.73e-09 | 12 | 73 | 4 | 8918877 | ||
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 8.87e-09 | 3 | 73 | 3 | 34049963 | |
| Pubmed | 2.40e-08 | 15 | 73 | 4 | 9264260 | ||
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 3.54e-08 | 4 | 73 | 3 | 18065749 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A1 GRAMD1B COL4A5 COL5A1 ABCC3 XPO6 SURF4 GRAMD1A NAGA SEL1L3 LAMB3 CERCAM SLC39A14 PTGFRN | 1.76e-07 | 1201 | 73 | 14 | 35696571 |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 1.77e-07 | 6 | 73 | 3 | 9506531 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 7495302 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 1.77e-07 | 6 | 73 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 1.77e-07 | 6 | 73 | 3 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 1.77e-07 | 6 | 73 | 3 | 6389236 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 1.77e-07 | 6 | 73 | 3 | 10534397 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 9068972 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 1.77e-07 | 6 | 73 | 3 | 9673377 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 1.77e-07 | 6 | 73 | 3 | 19275937 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 6988303 | ||
| Pubmed | 2.58e-07 | 26 | 73 | 4 | 24742657 | ||
| Pubmed | 3.09e-07 | 7 | 73 | 3 | 10639489 | ||
| Pubmed | 3.09e-07 | 7 | 73 | 3 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 3.09e-07 | 7 | 73 | 3 | 8006028 | |
| Pubmed | 3.09e-07 | 7 | 73 | 3 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 3.09e-07 | 7 | 73 | 3 | 10716744 | |
| Pubmed | 3.09e-07 | 7 | 73 | 3 | 1724753 | ||
| Pubmed | 3.09e-07 | 7 | 73 | 3 | 7521231 | ||
| Pubmed | 3.09e-07 | 7 | 73 | 3 | 17418794 | ||
| Pubmed | 4.08e-07 | 29 | 73 | 4 | 22613833 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 3997552 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 29422532 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 1383086 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 1377218 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 10382266 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 4.93e-07 | 8 | 73 | 3 | 10970885 | |
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 8562707 | ||
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 9878537 | ||
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 12101409 | ||
| Pubmed | 1.05e-06 | 10 | 73 | 3 | 9415455 | ||
| Pubmed | 1.05e-06 | 10 | 73 | 3 | 9136074 | ||
| Pubmed | 1.45e-06 | 11 | 73 | 3 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.45e-06 | 11 | 73 | 3 | 7500359 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 1.45e-06 | 11 | 73 | 3 | 9731539 | |
| Pubmed | 1.54e-06 | 40 | 73 | 4 | 27068110 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.93e-06 | 12 | 73 | 3 | 12180907 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 1.93e-06 | 12 | 73 | 3 | 15837576 | |
| Pubmed | 1.93e-06 | 12 | 73 | 3 | 16024816 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 2.50e-06 | 13 | 73 | 3 | 9833687 | |
| Pubmed | 3.18e-06 | 14 | 73 | 3 | 12878203 | ||
| Pubmed | 3.96e-06 | 15 | 73 | 3 | 10625553 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 3.96e-06 | 15 | 73 | 3 | 10706142 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15583824 | ||
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 4.35e-06 | 2 | 73 | 2 | 17980168 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 35177655 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21143337 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 34400539 | ||
| Pubmed | Possible Digenic Disease in a Caucasian Family with COL4A3 and COL4A5 Mutations. | 4.35e-06 | 2 | 73 | 2 | 30661074 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15364545 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16940319 | ||
| Pubmed | Guidelines for Genetic Testing and Management of Alport Syndrome. | 4.35e-06 | 2 | 73 | 2 | 34930753 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 33401997 | ||
| Pubmed | Discordance between skin biopsy and kidney biopsy in an X-linked carrier of Alport syndrome. | 4.35e-06 | 2 | 73 | 2 | 17294221 | |
| Pubmed | Aster Proteins Regulate the Accessible Cholesterol Pool in the Plasma Membrane. | 4.35e-06 | 2 | 73 | 2 | 32719109 | |
| Pubmed | 4.87e-06 | 16 | 73 | 3 | 15878328 | ||
| Pubmed | 5.79e-06 | 212 | 73 | 6 | 19521566 | ||
| Pubmed | 7.08e-06 | 18 | 73 | 3 | 9160753 | ||
| Pubmed | 8.39e-06 | 19 | 73 | 3 | 15689378 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 9.09e-06 | 62 | 73 | 4 | 28344315 | |
| Pubmed | 1.15e-05 | 21 | 73 | 3 | 23325811 | ||
| Pubmed | 1.15e-05 | 21 | 73 | 3 | 27856617 | ||
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 1.30e-05 | 3 | 73 | 2 | 27576055 | |
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 1.30e-05 | 3 | 73 | 2 | 15954103 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 14676276 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 3025878 | ||
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 1.30e-05 | 3 | 73 | 2 | 27859054 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 17396119 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 24522496 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 6386565 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 7962065 | ||
| Pubmed | Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome. | 1.30e-05 | 3 | 73 | 2 | 28542346 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 34691289 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28704582 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 18930919 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 1.30e-05 | 3 | 73 | 2 | 30647093 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 38978054 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 20301386 | ||
| Pubmed | Pathogenicity of a Human Laminin β2 Mutation Revealed in Models of Alport Syndrome. | 1.30e-05 | 3 | 73 | 2 | 29263159 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 36130833 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 14507670 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 1.30e-05 | 3 | 73 | 2 | 38433557 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 25575550 | ||
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 1.30e-05 | 3 | 73 | 2 | 27377778 | |
| Pubmed | Functional interaction between COL4A1/COL4A2 and SMAD3 risk loci for coronary artery disease. | 1.30e-05 | 3 | 73 | 2 | 26310581 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 24033287 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 14633121 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.38e-05 | 79 | 73 | 4 | 18757743 | |
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 2.60e-05 | 4 | 73 | 2 | 7827955 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 2.60e-05 | 4 | 73 | 2 | 11185557 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 19278955 | ||
| Pubmed | Two-hybrid analysis reveals multiple direct interactions for thrombospondin 1. | 2.60e-05 | 4 | 73 | 2 | 9840442 | |
| Interaction | MMP9 interactions | 3.57e-06 | 67 | 70 | 5 | int:MMP9 | |
| Interaction | DCN interactions | 1.49e-05 | 43 | 70 | 4 | int:DCN | |
| Cytoband | 19p13.1 | 2.68e-03 | 48 | 73 | 2 | 19p13.1 | |
| Cytoband | 16p11.2 | 3.56e-03 | 191 | 73 | 3 | 16p11.2 | |
| GeneFamily | Collagens | 1.31e-05 | 46 | 57 | 4 | 490 | |
| GeneFamily | Cytochrome P450 family 4 | 1.97e-04 | 36 | 57 | 3 | 1003 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 7.45e-04 | 13 | 57 | 2 | 1146 | |
| GeneFamily | Solute carriers | 1.48e-03 | 395 | 57 | 6 | 752 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.45e-07 | 23 | 72 | 4 | M48001 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.54e-06 | 71 | 72 | 5 | M3955 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.44e-06 | 40 | 72 | 4 | M5887 | |
| Coexpression | NABA_COLLAGENS | 5.96e-06 | 43 | 72 | 4 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 6.54e-06 | 44 | 72 | 4 | M3005 | |
| Coexpression | BILBAN_B_CLL_LPL_UP | 2.94e-05 | 64 | 72 | 4 | M19930 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-08 | 180 | 73 | 7 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.86e-08 | 191 | 73 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.97e-08 | 192 | 73 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 3.18e-08 | 194 | 73 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.30e-08 | 195 | 73 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.77e-07 | 162 | 73 | 6 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-07 | 180 | 73 | 6 | efc4c5a4dea456527526bbfd88cf70d803893671 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.05e-07 | 190 | 73 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.50e-07 | 192 | 73 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.73e-07 | 193 | 73 | 6 | c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 7.73e-07 | 193 | 73 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.73e-07 | 193 | 73 | 6 | 682ce63b73a7d02eef240673db67058d7507f744 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 7.96e-07 | 194 | 73 | 6 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.21e-07 | 195 | 73 | 6 | 53b83e16b350100b1d5791a9c42bd98e37cbc0af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.24e-07 | 199 | 73 | 6 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-06 | 145 | 73 | 5 | 8da10bc6611976e1ec85e09f04a2dc5bf6555c9e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-06 | 151 | 73 | 5 | 16fc903fc71e25717b9908416f0bcd29c0a65a61 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.60e-06 | 160 | 73 | 5 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.22e-06 | 163 | 73 | 5 | 13f76f2979558f5cd27fbfd1659b413b3cac18f5 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-06 | 167 | 73 | 5 | ed7e785dcd25777f64e0c2596ada4f5a5ea17121 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.61e-06 | 169 | 73 | 5 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-06 | 173 | 73 | 5 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-06 | 173 | 73 | 5 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.02e-05 | 175 | 73 | 5 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 180 | 73 | 5 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-05 | 180 | 73 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 180 | 73 | 5 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-05 | 183 | 73 | 5 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 184 | 73 | 5 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 185 | 73 | 5 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 186 | 73 | 5 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | facs-Heart-LV-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 187 | 73 | 5 | 1bc338c22d645a854f8d8eb8a064c441121fb673 | |
| ToppCell | Endothelial-B|World / lung cells shred on cell class, cell subclass, sample id | 1.44e-05 | 188 | 73 | 5 | 5959a88728812a5f4cbfa54eddc7a73ccbaa2f68 | |
| ToppCell | PND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.48e-05 | 189 | 73 | 5 | eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-05 | 189 | 73 | 5 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.48e-05 | 189 | 73 | 5 | d4a25d59d88325d3b20f4287e9b1160c82961a96 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 190 | 73 | 5 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-05 | 190 | 73 | 5 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 190 | 73 | 5 | 65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.63e-05 | 193 | 73 | 5 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-05 | 193 | 73 | 5 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | severe-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.63e-05 | 193 | 73 | 5 | f4d43dfbf4115dd0f843ea5cf08049220342a047 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 193 | 73 | 5 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-05 | 194 | 73 | 5 | 6115c20ffe414378508f3879e67815b6062341a7 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-05 | 194 | 73 | 5 | 6317e9cdf96eb020f84d50bf41f803db5c9c04a0 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.68e-05 | 194 | 73 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-05 | 194 | 73 | 5 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | PND28-Endothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-05 | 194 | 73 | 5 | b592c713204db7ae2f34a54f2d03d13834593c57 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-05 | 194 | 73 | 5 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-05 | 195 | 73 | 5 | 65fc50e3818e902028fc4226070fa57609c66b9c | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.72e-05 | 195 | 73 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.72e-05 | 195 | 73 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-05 | 195 | 73 | 5 | 3b79e6bb525b17192ecec9e1227a29c419968144 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 195 | 73 | 5 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-05 | 196 | 73 | 5 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-05 | 196 | 73 | 5 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 197 | 73 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 197 | 73 | 5 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | tumor_Lung-Endothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 1.80e-05 | 197 | 73 | 5 | 6870b311c54a73723768276a58456620f5217d43 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 197 | 73 | 5 | a312d9cf4ced949307eb9620be4eed926300b892 | |
| ToppCell | (4)_Blood_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.80e-05 | 197 | 73 | 5 | 1b82979a41ef46c814c82527a585900586d71260 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 197 | 73 | 5 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | (4)_Endothelial_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.80e-05 | 197 | 73 | 5 | dd9abb43c23e7698433e455eacbf5b23b0a756c2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 197 | 73 | 5 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb | |
| ToppCell | (6)_Endothelial_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.85e-05 | 198 | 73 | 5 | f38f49d532fa6211f57e36ee494478bdd3f4f89c | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|tumor_Lung / Location, Cell class and cell subclass | 1.85e-05 | 198 | 73 | 5 | 5228c4bf2513186140c2c4eaa67a268c732bdc84 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.85e-05 | 198 | 73 | 5 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 198 | 73 | 5 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | (6)_Endothelial-A_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.85e-05 | 198 | 73 | 5 | 44f8cd5afa3685dcc8bfea0b15af5e8817e12e2e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 198 | 73 | 5 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 198 | 73 | 5 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.85e-05 | 198 | 73 | 5 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | (6)_Endothelial-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.85e-05 | 198 | 73 | 5 | a5e1b321376caf262ea48904d31afd1b8e9d3be2 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 199 | 73 | 5 | 6cfe5a3d0ad530411ebc11decb4ab4c529e018d5 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 199 | 73 | 5 | 82758d0cee9387d002e3f68a6faa324134fb7564 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 199 | 73 | 5 | 920299626a9ec8e50d944f5a7667e855de7edd72 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 199 | 73 | 5 | ddfb725ccbcadbd188e20b60a7567e1f8245f18d | |
| ToppCell | normal_Lung-Endothelial_cells|normal_Lung / Location, Cell class and cell subclass | 1.89e-05 | 199 | 73 | 5 | 6dff5e10370d2b43afe6e3428f5f3aa37ccc32ff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 73 | 5 | 2e51195810bca8a98488a8a06c538feaa27f1f28 | |
| ToppCell | distal-1-Endothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | 8f25b27c10e89cf9d0091bd53c24ce63ed7d6222 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 73 | 5 | 30dc7ffef2052ee8610cdca952ca12f240bcec50 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | distal-Endothelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | b17c9607d4986f8f1facc6b564d4c15c48e58915 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.94e-05 | 200 | 73 | 5 | ec92fe4eafe527d351ee73c9735e96855ac506a3 | |
| ToppCell | distal-2-Endothelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | bc1781cff7a4602057a59ef65cf16c3a9459c628 | |
| ToppCell | distal-3-Endothelial|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | c000264843f611a28a473b5a92195b163f46c4f4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 200 | 73 | 5 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-05 | 133 | 73 | 4 | f303ab771482281d8793974f9f5279cee09431fe | |
| ToppCell | P03-Hematopoietic|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.51e-05 | 141 | 73 | 4 | 4a856521520ea73291f4730fe94c5de88c2b6f0c | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 9.99e-05 | 147 | 73 | 4 | 4ba9a86ab7033688a9a2a2dc84c001a49af835b4 | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-04 | 149 | 73 | 4 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-04 | 149 | 73 | 4 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 155 | 73 | 4 | a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-04 | 155 | 73 | 4 | 93bfcf5c12cbb61a1e0444312afd2aa411a8bf50 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-04 | 155 | 73 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.26e-04 | 156 | 73 | 4 | c380142e49b1e4ecacbf37587aafa57f8562b6ad | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 159 | 73 | 4 | d2de9391b00b6c47f5fe28a1bad6da2097107ee0 | |
| Drug | Madecassol | 3.40e-07 | 46 | 72 | 5 | CID000108062 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 2.27e-06 | 189 | 72 | 7 | CID000001413 | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.09e-06 | 198 | 72 | 7 | 4413_UP | |
| Drug | GK-101 | 5.02e-06 | 36 | 72 | 4 | CID000161853 | |
| Drug | halofuginone lactate | 7.40e-06 | 85 | 72 | 5 | CID000062891 | |
| Drug | AC1L18QD | 8.56e-06 | 325 | 72 | 8 | CID000000213 | |
| Drug | tienilic acid | 1.15e-05 | 93 | 72 | 5 | CID000038409 | |
| Drug | Taurochenodeoxycholic Acid | 1.34e-05 | 15 | 72 | 3 | ctd:D013655 | |
| Drug | d-indobufen | 1.90e-05 | 50 | 72 | 4 | CID000044562 | |
| Drug | ridogrel | 2.22e-05 | 52 | 72 | 4 | CID005362391 | |
| Drug | NSC49633 | 2.39e-05 | 53 | 72 | 4 | CID000023340 | |
| Drug | CP-331 | 2.95e-05 | 3 | 72 | 2 | CID000130967 | |
| Drug | PPACK | 2.96e-05 | 113 | 72 | 5 | CID003036757 | |
| Drug | perfluorodecalin | 3.33e-05 | 20 | 72 | 3 | CID000009386 | |
| Drug | dimethylnitrosamine | 3.67e-05 | 196 | 72 | 6 | CID000006124 | |
| Drug | Bezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 2630_UP | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; PC3; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 5082_UP | |
| Drug | benzphetamine | 3.79e-05 | 119 | 72 | 5 | CID000002341 | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 3423_DN | |
| Drug | AC1LAKND | 4.46e-05 | 62 | 72 | 4 | CID000470146 | |
| Drug | Brn 2557402 | 5.89e-05 | 4 | 72 | 2 | CID000042742 | |
| Drug | 2f1b | 6.06e-05 | 67 | 72 | 4 | CID011963508 | |
| Drug | propoxyphene | 6.06e-05 | 67 | 72 | 4 | CID000010100 | |
| Drug | BAPN | 7.61e-05 | 71 | 72 | 4 | CID000001647 | |
| Drug | malotilate | 7.61e-05 | 71 | 72 | 4 | CID000004006 | |
| Drug | DL-penicillamine | 7.95e-05 | 139 | 72 | 5 | CID000004727 | |
| Drug | PCR 4099 | 7.95e-05 | 139 | 72 | 5 | CID000002806 | |
| Drug | AC1NMZ1B | 9.43e-05 | 75 | 72 | 4 | CID005034185 | |
| Drug | dimethylmalonimidate | 9.80e-05 | 5 | 72 | 2 | CID000189133 | |
| Drug | Cyclo-rgdphg | 9.80e-05 | 5 | 72 | 2 | CID006449872 | |
| Drug | strontium ranelate | 1.04e-04 | 77 | 72 | 4 | CID006918182 | |
| Drug | prostacyclin sodium salt | 1.41e-04 | 250 | 72 | 6 | CID000000159 | |
| Drug | 4-fluoranylproline | 1.47e-04 | 6 | 72 | 2 | CID000450594 | |
| Disease | collagen disease (implicated_via_orthology) | 2.65e-06 | 12 | 69 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 7.35e-06 | 53 | 69 | 4 | C4707243 | |
| Disease | Alport syndrome (is_implicated_in) | 1.61e-05 | 3 | 69 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | Alport syndrome | 1.61e-05 | 3 | 69 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 1.61e-05 | 3 | 69 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 3.22e-05 | 4 | 69 | 2 | C0241908 | |
| Disease | Alport Syndrome | 3.22e-05 | 4 | 69 | 2 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 5.36e-05 | 5 | 69 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 5.36e-05 | 5 | 69 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 5.36e-05 | 5 | 69 | 2 | C1567744 | |
| Disease | corneal topography | 1.27e-04 | 109 | 69 | 4 | EFO_0004345 | |
| Disease | Hematuria | 1.92e-04 | 9 | 69 | 2 | C0018965 | |
| Disease | immunoglobulin M measurement | 1.92e-04 | 9 | 69 | 2 | EFO_0020466 | |
| Disease | myopathy (implicated_via_orthology) | 1.96e-04 | 48 | 69 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Blood Coagulation Disorders | 6.33e-04 | 16 | 69 | 2 | C0005779 | |
| Disease | neoplasm of mature B-cells | 9.96e-04 | 20 | 69 | 2 | EFO_0000096 | |
| Disease | serum IgM measurement | 1.21e-03 | 22 | 69 | 2 | EFO_0004993 | |
| Disease | Renal glomerular disease | 1.32e-03 | 23 | 69 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.32e-03 | 23 | 69 | 2 | C4521256 | |
| Disease | inflammatory biomarker measurement | 1.69e-03 | 26 | 69 | 2 | EFO_0004872 | |
| Disease | sodium measurement | 1.83e-03 | 103 | 69 | 3 | EFO_0009282 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QTYYCSTACQRRDWS | 186 | Q9BXT4 | |
| GSCTTLLVYVRYAWQ | 236 | P0CF97 | |
| CNFASRNDYSYWLST | 1511 | Q01955 | |
| YAQYWDSTISSGLCI | 381 | O43506 | |
| GLYTSAYWCGQALVD | 1051 | Q8N139 | |
| GTVWINCYNALYAQA | 461 | P47895 | |
| ETAWALQSLGYTCYS | 1031 | Q8NFM4 | |
| IVTQYCVGANYTWLL | 221 | P48546 | |
| QGRLYLSENWICFYS | 121 | Q96CP6 | |
| QGRLYLSENWICFYS | 126 | Q3KR37 | |
| YDAAPLTWSRCSRQY | 421 | Q9UKP4 | |
| CNFASRNDYSYWLST | 1511 | P02462 | |
| YSGYWSLCAAVNRAL | 96 | Q5T6V5 | |
| NQRSCYPYIISNRWL | 1181 | O15438 | |
| CYYAVSWLRQGFSIN | 41 | Q9Y442 | |
| CYLQTDSIAYWNATR | 51 | P55344 | |
| TYNWNDCYIASGSLS | 126 | Q8NHV4 | |
| RLATYSQLYQAWTEG | 176 | Q9GZV7 | |
| NQSRRGYWSCLLVYL | 76 | Q8TDU6 | |
| ITCQASEGIGNYLYW | 41 | A0A0C4DH26 | |
| ALTSLFLWYCYRLGS | 86 | Q5U4P2 | |
| YRCSYQNGSLWSLPS | 86 | Q9HCN6 | |
| LVFCNSSSTVNWLGY | 401 | Q9NUL7 | |
| NSYGSQWSPDYRCSV | 1111 | Q9HD67 | |
| QWSPDYRCSVGTYNS | 1116 | Q9HD67 | |
| IGYQCSRLYWSTVDA | 1756 | Q9UMN6 | |
| GNSYRLQSWLYSSRL | 126 | O95299 | |
| YQWILCQGSNYSTCA | 56 | Q96E93 | |
| SRLYDCVWRYNSSVN | 346 | Q9UJP4 | |
| GCFLLWNLYVSSSQT | 11 | Q8NFQ6 | |
| QVVWYSSYLVGCGNA | 141 | P54108 | |
| LARVLAWTYTFYDNC | 31 | Q9HBI6 | |
| VCNFASRNDYSYWLS | 1526 | P29400 | |
| LARILAWTYAFYNNC | 31 | Q9HCS2 | |
| CYQSVAWQDAATGSY | 1746 | P20908 | |
| IVWLTQYYTSCNDLT | 116 | Q9Y4D2 | |
| KTWRVYQYLAADCTS | 141 | Q13751 | |
| YLASGAWQSSCYRPI | 136 | Q3LI77 | |
| LARILAWTYTFYDNC | 31 | Q08477 | |
| NWAIDRCYTGSYQLA | 1221 | Q5TBA9 | |
| YNLANTARCWTYLTG | 306 | Q9BY41 | |
| LDSQTYYSNFWCGIT | 171 | Q5T4B2 | |
| QASQSACYWLKGVRY | 316 | Q15043 | |
| SCLVSRDGNVSYAWY | 156 | Q9BZW8 | |
| AIARSLYYNDNCWIS | 271 | Q16602 | |
| GNYYCVVSAWTKQRN | 511 | Q9P2B2 | |
| EGTLWCSLYYITGNL | 836 | Q68CR1 | |
| RYAYEWQRCLGSALN | 1126 | Q9UMZ2 | |
| PGSACRAWAYYSAVN | 1721 | P12259 | |
| SNYSSWHYRSCLLPQ | 176 | Q92696 | |
| SRACKNSTLANYLYW | 481 | Q8NEB9 | |
| LAWISQGLYSCLETY | 331 | Q96JW4 | |
| QRDYIDTTWNCGYLL | 51 | O15260 | |
| YWSDYRDALSLQCLA | 466 | Q2Y0W8 | |
| RTRSWLYAACSISYL | 81 | P78383 | |
| ECQGSSAVSYFWYRQ | 151 | Q96N87 | |
| NYGQSETGLICATYW | 366 | Q08AH1 | |
| ICVRSSLWTNYSAYS | 61 | Q96FZ5 | |
| FQYGWRCTTNENTYS | 51 | Q9H5F2 | |
| SSITACILIYWYRQG | 71 | Q9BU79 | |
| WVRGCRAALLSYYSS | 246 | P23942 | |
| FWCSISYYELNQRVG | 231 | P84022 | |
| LYPNYQSCWSLRQRT | 201 | Q9NPH0 | |
| WAAQETCYQLRYTGE | 416 | P40238 | |
| RSYANGNWIYGDVLC | 81 | Q9BXA5 | |
| GNWIYGDVLCISNRY | 86 | Q9BXA5 | |
| PYTNLSWSCYLNIGA | 161 | Q9BSN7 | |
| SNTWCDLGINYYRQA | 776 | Q6PGP7 | |
| QIGAWRFCLYFLSST | 41 | Q96QU8 | |
| IYTGLWSYNCVLSCI | 341 | Q15849 | |
| VWSAPNYCYRCGNVA | 256 | P60510 | |
| WYNCLTLAIYGSVDR | 116 | Q69YN4 | |
| YERLLYVTCSQNWEA | 2471 | Q9Y4A5 | |
| RQWNTLYLCGTDEYG | 301 | P56192 | |
| NYLYDRSLWNSVCLE | 151 | Q96DZ7 | |
| SGRAEYYQWVGICTS | 156 | Q9H6D3 | |
| YQGTCRCAGTIYLWN | 666 | Q92539 | |
| NYSLLADICNLWRNY | 201 | P17050 |